On February 29, Spectral AI announced that Peter M. Carlson, its current chief financial officer (CFO), will take over the role as CEO and board member of the medical diagnostics company. Carlson will succeed Wensheng Fan, who will take an advisor role after nearly four years as CEO and 14 years with the company. The move comes after the Dallas, Texas-based company made its initial public offering (IPO) on September 12, 2023, on the Nasdaq, trading under MDAI.
“We are confident he is the right person to guide Spectral AI as we evolve from a late-stage development company and commercialize our revolutionary, AI-driven wound care technology,” said Richard Cotton, chairman of the company’s board of directors.
Before joining Spectral AI, Carlson served as chief operating officer at Brighthouse Financial and chief accounting officer for MetLife. Carlson joined Spectral AI as its CFO in January of this year.
Spectral AI, which develops AI tools for medical diagnostics, received full UK Conformity Assessed (UKCA) authorization for its predictive software DeepView AI-Burn. The software helps clinicians assess a wound’s healing potential prior to medical intervention. The company also enrolled its first patient a study to validate DeepView AI for burn size and healing assessments and plans to seek FDA marketing authorization for the software in 2025. It is also investigating other clinical applications for DeepView, including its use for venous leg ulcers, critical limb ischemia, guided therapy, and more (1).
Technology. Spectral AI, Inc. 2024. https://www.spectral-ai.com/wound-healing-technologies/ (accessed 2024-3-1)
Young Scientist Awardee Uses Spectrophotometry and AI for Pesticide Detection Tool
November 11th 2024Sirish Subash is the winner of the Young Scientist Award, presented by 3M and Discovery education. His work incorporates spectrophotometry, a nondestructive method that measures the light of various wavelengths that is reflected off fruits and vegetables.
Best of the Week: Cancer Biomarkers and Screening, Raman for Hematology Diagnostics
November 8th 2024Top articles published this week include an interview with Landulfo Silveira Jr., an article about using Raman spectroscopy in hematology, and a recap of a recent study that used infrared (IR) spectroscopy to screen for cancer.
Emerging Leader Highlights Innovations in Machine Learning, Chemometrics at SciX Awards Session
October 23rd 2024Five invited speakers joined Joseph Smith, the 2024 Emerging Leader in Molecular Spectroscopy, on stage to speak about trends in hyperspectral imaging, FT-IR, surface enhanced Raman spectroscopy (SERS), and more during the conference in Raleigh.
Advancing Forensic Science with Chemometrics: New Tools for Objective Evidence Analysis
October 22nd 2024A review by researchers from Curtin University comprehensively explores how chemometrics can revolutionize forensic science by offering objective and statistically validated methods to interpret evidence. The chemometrics approach seeks to enhance the accuracy and reliability of forensic analyses, mitigating human bias and improving courtroom confidence in forensic conclusions.